Guardant Health Inc.
Guardant Health to Host Investor Day on September 24, 2025
Summary
Guardant Health, Inc. will host an Investor Day on September 24, 2025, starting at 9:00 a.m. Eastern Time in New York City. The event will feature remarks from the co-Chief Executive Officers, Helmy Eltoukhy and AmirAli Talasaz, and other members of the executive management team. The presentation aims to highlight the company's operations and provide updates on its key strategic priorities and financial outlook. Interested parties can access the live and archived webcast of the presentation on the 'Investors' section of the company's website at www.guardanthealth.com.
Profitelligence Alerts
Get alerts for GH
Be first to know when Guardant Health Inc. files with the SEC.
Filing Categories
Advertisement
About Guardant Health Inc.
Guardant Health Inc. is an innovative biotechnology company specializing in the development and commercialization of precision oncology diagnostics. This company is recognized for its groundbreaking work in non-invasive cancer detection through liquid biopsy technologies, which involve analyzing circulating tumor DNA in blood samples. Guardant Health’s primary function is to provide oncologists and researchers with critical tools and data to better understand cancer, tailor treatments, and monitor disease progression, potentially improving patient outcomes significantly. Guardant Health operates prominently in the healthcare and biotechnology sector, significantly impacting fields such as cancer research and personalized medicine. Their products and services are vital for facilitating early detection of cancer, identifying treatment options, and offering companion diagnostics for pharmaceutical developments. In the financial market, Guardant Health represents an important player within the precision medicine landscape, influencing investment within the biotechnology and healthcare sectors. Founded in 2012 and headquartered in Redwood City, California, the company continues to expand its portfolio and advance its technologies, playing a pivotal role in the fight against cancer at a global level.
Official SEC Documents
Advertisement